CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
LATAM
CANADA
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • About
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended Insights

How COVID-19 will Accelerate Digital...

Jakirul Islam, Senior Vice President, Bank Asia

Sterile Processing Professional: 30 Years...

Jackie Mallatt, CRCST, Sterile Processing...

Packaging, A Key Element In Improving...

Bertrand Havrileck, Head of Corporate Pharma R&D,...

What Role Does Digital Technology Play in...

Jeremy Williams, Life Science Review

Managing Risk and Minimizing the...

Timothy Korwan, Director, New Product Development...

In Personalized Medicine Logistics,...

Scott Ohanesian, Senior VP Commercial Operations,...

Unlock the Power of Data

Jijo James, M.D., M.P.H., Chief Medical Officer,...

A Growing Reliance on Outsourcing Warrants...

Greg Aimi, Vice President, Team Manager, Supply...

How COVID-19 will Accelerate Digital...

Jakirul Islam, Senior Vice President, Bank Asia

Sterile Processing Professional: 30 Years...

Jackie Mallatt, CRCST, Sterile Processing...

Packaging, A Key Element In Improving...

Bertrand Havrileck, Head of Corporate Pharma R&D,...

What Role Does Digital Technology Play in...

Jeremy Williams, Life Science Review

Managing Risk and Minimizing the...

Timothy Korwan, Director, New Product Development...

In Personalized Medicine Logistics,...

Scott Ohanesian, Senior VP Commercial Operations,...

Unlock the Power of Data

Jijo James, M.D., M.P.H., Chief Medical Officer,...

A Growing Reliance on Outsourcing Warrants...

Greg Aimi, Vice President, Team Manager, Supply...

Top Biotech Developments to Watch for

Jeremy Williams, Life Science Review
Tweet

To open the study process to a much wider community of stakeholders, software resources that promote collaboration, data sharing, and interactive meetings allow groups to work together regardless of where they are located.


Current biotechnology mainly focuses on medicine. Small start-ups are developing new treatment methods for rare and complex disorders and genetic testing to classify inherited diseases, global pharmaceutical firms, and government funding agencies in this area. Other fields of biotechnology include alternative energy, agriculture, and environmental science.


Top biotechnology developments include:


Increased Stakeholder Collaboration


The opportunity to facilitate cooperation among stakeholders representing numerous organizations, whether global corporations, smaller companies, academic institutions, or government research organizations, is another advantage of cloud computing. To open the study process to a much wider community of stakeholders, software resources that promote collaboration, data sharing, and interactive meetings allow groups to work together regardless of where they are located. 


Increased collaboration presents a potential threat to practitioners in biotechnology. For wider teams collaborating on projects, and with some projects taking several years to gain regulatory approval or produce a return on investment, with the technologies they are making, people and the organizations they serve need to consider intellectual property rights. Otherwise, the products they make could not benefit financially from them.


Growth in Personalized Diagnosis of Rare Diseases


From 2.7 billion dollars for the Human Genome Project in 1990 to less than 300 dollars currently, and possibly less than 100 dollars shortly, the decreased cost of genetic sequencing allows for far more rigorous screening and intervention targeting of study subjects. This has allowed customized therapy strategies and tailored therapies to be created, which are more successful than less precise treatments since they rely on the genetic and molecular composition of a patient.


The main area of focus for tailored treatments is cancer care. One famous example is blood cancer, such as leukemia, where a procedure called CAR T-cell therapy targets the immune cells of a patient, and the immune system can attack tumors.


Weekly Brief

loading
Towards a New World Order
> <
  • Therapeutics 2022

    Top Vendors

    Current Issue
  • Life Science Compliance 2022

    Top Vendors

    Current Issue
  • DNA Sequencing 2022

    Top Vendors

    Current Issue
  • Therapeutics 2022

    Top Vendors

    Current Issue
  • Life Science Compliance 2022

    Top Vendors

    Current Issue
  • DNA Sequencing 2022

    Top Vendors

    Current Issue

Read Also

Specialized Services: A New Paradigm in Therapeutics

Brian D. Fry, Senior Director, Cell Therapy CDMO, Charles River Laboratories

Setting A Culture for Digital Transformation in the Biopharmaceutical Industry

Ross Kenyon, Associate Director – Modeling, Simulation and Analysis, Regeneron Pharmaceuticals

The 7 TIPS for a Successful Master Data Migration and Ongoing Data Quality Management

Marc Jenny, Senior Director, Customer Engagement Systems & Advanced Analytics Strategy Lead, Interl. & Japan, Alexion Pharmaceuticals

The Challenges Of Bringing Phytocannabinoid Plant-Based Medicines To Market

Ron Lipsky, Vice President, Business Development & International Relations at MGC Pharmaceuticals, Ltd.

Take Advantage of Technology in Infection Prevention!

Kimberly Atrubin, Director, Infection Prevention, Tampa General Hospital

Digital Innovation

Iris Loew-Friedrich, EVP & Chief Medical Officer, UCB

New Innovative Probiotics Reduces Risk of Aspirin-Induced Ulcers

Anders Damholt, PhD Biochemistry, Head of Clinical Development Human Health Innovation & Sara Engel, PhD Human Nutrition, Senior Clinical Development Scientist, Human Health Innovation

The Rise in Outsourcing Clinical Trials

Erika Vento-Gaudens, Director, Global Clinical Trial Operations at Guardant Health
Loading...

Copyright © 2022 Life Science Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/top-biotech-developments-to-watch-for-nwid-272.html